🇺🇸 FDA
Patent

US 10004782

Glucokinase activator compositions for the treatment of diabetes

granted A61KA61K31/426A61K31/4985

Quick answer

US patent 10004782 (Glucokinase activator compositions for the treatment of diabetes) held by VTV THERAPEUTICS LLC expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/426, A61K31/4985, A61K38/22, A61K38/26